Literature DB >> 15258031

Indomethacin lowers optic nerve oxygen tension and reduces the effect of carbonic anhydrase inhibition and carbon dioxide breathing.

D B Pedersen1, T Eysteinsson, E Stefánsson, J F Kiilgaard, M La Cour, K Bang, P K Jensen.   

Abstract

BACKGROUND/AIMS: Prostaglandins are important in blood flow regulation. Carbon dioxide (CO(2)) breathing and carbonic anhydrase inhibition increase the oxygen tension in the retina and optic nerve. To study the mechanism of this effect and the role of cyclo-oxygenase in the regulation of optic nerve oxygen tension (ONPO(2)), the authors investigated how indomethacin affects ONPO(2) and the ONPO(2) increases caused by CO(2) breathing and carbonic anhydrase inhibition in the pig.
METHODS: Optic nerve oxygen tension was measured in 11 pigs with a polarographic oxygen electrode. The tip of the electrode was placed 0.5 mm above the optic disc. The effects of indomethacin, CO(2) breathing (3%) before and after indomethacin treatment, and carbonic anhydrase inhibition with or without indomethacin treatment were investigated.
RESULTS: Administration of 300 mg indomethacin decreased optic nerve oxygen tension significantly. Carbonic anhydrase inhibition and CO(2) breathing increased ONPO(2) significantly. After indomethacin had been given, the rise in ONPO(2) caused by CO(2) breathing and carbonic anhydrase inhibition was significantly reduced.
CONCLUSION: Systemic administration of indomethacin decreases the optic nerve oxygen tension; this is probably the result of decreased blood flow through vasoconstriction of vessels in the optic nerve. Additionally, indomethacin diminishes the ONPO(2) increasing effect of CO(2) breathing and carbonic anhydrase inhibition, thus affecting the reactivity of vessels in the optic nerve.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258031      PMCID: PMC1772262          DOI: 10.1136/bjo.2003.041251

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors.

Authors:  E Stefánsson; P K Jensen; T Eysteinsson; K Bang; J F Kiilgaard; J Dollerup; E Scherfig; M la Cour
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

2.  Effects of indomethacin on regional blood flow in conscious rabbits--a microsphere study.

Authors:  A Bill
Journal:  Acta Physiol Scand       Date:  1979-04

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

4.  Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man.

Authors:  S Eriksson; L Hagenfeldt; D Law; C Patrono; E Pinca; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1983-02

5.  Studies on the role of prostaglandins in the regulation of retinal blood flow.

Authors:  C Pournaras; M Tsacopoulos; P Chapuis
Journal:  Exp Eye Res       Date:  1978-06       Impact factor: 3.467

6.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

7.  Influence of nitrovasodilators and cyclooxygenase inhibitors on cerebral vasoreactivity in conscious rabbits.

Authors:  K Csete; P Barzó; M Bodosi; J G Papp
Journal:  Eur J Pharmacol       Date:  2001-02-02       Impact factor: 4.432

8.  Effect of indomethacin on CO2-induced hyperaemia (CO2-response) in the rabbit brain.

Authors:  J Cuypers; A Cuevas; R Duisberg
Journal:  Neurochirurgia (Stuttg)       Date:  1978-03

9.  The effect of indomethacin on cerebral blood flow and oxygen consumption in the rat at normal and increased carbon dioxide tensions.

Authors:  N Dahlgren; B Nilsson; T Sakabe; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1981-04

10.  Effects of indomethacin on cerebral blood flow during hypercapnia in cats.

Authors:  D W Busija; D D Heistad
Journal:  Am J Physiol       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.